Institute of Immunology and Infection Research, University of Edinburgh, Edinburgh, UK.
Parasite Immunol. 2011 Jan;33(1):73-8. doi: 10.1111/j.1365-3024.2010.01251.x.
One of the most promising approaches in the efforts to produce a malaria vaccine involves the use of attenuated whole sporozoite immunizations. Attenuation may be achieved by the use of genetic modification, irradiation, chemical attenuation, or by the contemporaneous administration of antimalarial drugs that target only the erythrocytic stages of the parasite. Most research to date has focused on the efficacy of these approaches upon challenge with parasites homologous to those used for the initial immunizations. We, as have others, have previously shown that a component of the immunity achieved against the erythrocytic stages of the rodent malaria parasite Plasmodium chabaudi chabaudi is strain-specific, with a stronger immune response targeting the immunizing strain than genetically distinct strains. Here, we show that the immunity induced by infection with the pre-erythrocytic stages of these parasites, achieved via inoculation of sporozoites contemporaneously with mefloquine, also has a strain-specific component.
在研制疟疾疫苗的努力中,最有前途的方法之一是使用减毒的全孢子虫免疫接种。减毒可以通过基因修饰、辐照、化学减毒或同时使用仅针对寄生虫红细胞阶段的抗疟药物来实现。迄今为止,大多数研究都集中在这些方法在受到与最初免疫接种所用寄生虫同源的寄生虫挑战时的功效上。我们之前已经表明,针对啮齿动物疟原虫 Plasmodium chabaudi chabaudi 的红细胞阶段所获得的免疫的一个组成部分是菌株特异性的,针对免疫菌株的免疫反应比遗传上不同的菌株更强。在这里,我们表明,通过同时接种疟原虫孢子虫来感染这些寄生虫的红细胞前阶段所诱导的免疫也具有菌株特异性成分。